Key facts
- It has raised $2.1M; the latest was Early Stage VC ($2.1M) in Aug 2025.
- Notable investors include APT Medical.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Liliang Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Liliang Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Liliang Medical
Developer of a medical adhesive technology intended to enhance wound closure and tissue repair. The company offers biodegradable cyanoacrylate-based adhesives with rapid polymerization and low thermal output, enabling healthcare professionals to perform safe, efficient, and minimally invasive procedures.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Liliang Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Liliang Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Liliang Medical in its N-PORT filings yet. We sweep new filings monthly.